ClinConnect ClinConnect Logo
Search / Trial NCT06509698

Comparative Effects of Virtual Reality and Frenkel's Exercises in Patients With Stroke.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 15, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Balance Berg Balance Scale Frenkel's Exercises Gait Stroke

ClinConnect Summary

This clinical trial is studying the effects of two different rehabilitation methods for patients who have had a stroke: Virtual Reality (VR) exercises and Frenkel's exercises. The goal is to find out which method better helps improve balance, walking, and overall quality of life for stroke survivors. If you or a loved one is between the ages of 40 and 65 and has experienced a stroke, you might be eligible to participate in this study, especially if the stroke occurred recently and you haven't used VR rehabilitation before.

Participants in this trial can expect to engage in either VR exercises or traditional exercises designed to improve their physical abilities. The study is currently recruiting participants and aims to include individuals who have a good level of mental clarity, as measured by a simple test. However, those with serious mental health issues, recent injuries, or other specific health concerns may not qualify. This trial provides an opportunity to explore innovative rehabilitation options that could lead to better recovery outcomes for stroke patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1- Age 40-65 years. 2. Stroke patients with both genders. 3. Subacute stroke patients will be included. 4. Survivors of ischemic stroke. 5. No prior experience with VR-based rehabilitation. 6. Patients with ≥24 Mini-Mental State Exam score.
  • Exclusion Criteria:
  • 1. Patient with serious behavioral problems or mental health.
  • 2. Patients with recent lower extremity deep vein thrombosis, quadriplegia, Parkinson's disease, lower limb fractures, or recent myocardial infarction.
  • 3. Patients with malignant tumor, or other unstable condition.
  • 4. Participants with ENT defect, hearing, majorly affected vision(blindness), cataract, glaucoma, loss of vision.
  • 5. Subjects with diagnosed vestibular disease.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Alveena Fatima, Ms.NMPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported